Shanghai SIMR Biotech Co., Ltd. focuses on innovative biotechnological solutions, particularly in the fields of drug discovery and development. The company employs advanced methodologies in its research pipeline, which includes the use of high-throughput screening and molecular modeling techniques. These technologies enable the identification and optimization of potential therapeutic compounds, streamlining the process of bringing new drugs to market. Additionally, SIMR Biotech emphasizes the importance of precision medicine, utilizing genomic and proteomic data to tailor treatments to individual patient profiles.

In its commitment to advancing biopharmaceuticals, SIMR Biotech also integrates cutting-edge technologies such as CRISPR gene editing and synthetic biology. These tools facilitate the development of novel therapeutics and enhance the understanding of disease mechanisms at a molecular level. The company’s focus on collaborative research and development further strengthens its capabilities, allowing it to leverage external expertise and resources to accelerate innovation in the biotech sector. Through these technologies, Shanghai SIMR Biotech aims to contribute significantly to the advancement of healthcare solutions.

China

SIMR is an innovation-oriented biopharmaceutical company dedicated to the discovery and development of new drugs for pain, inflammation and central nervous system related diseases. Since its establishment in 2014, the company has established a research and development platform of more than 3,000 square meters, with comprehensive drug development capabilities such as compound screening, CMC research, preclinical evaluation, and clinical development.

Shanghai SIMR Biotech Co.,Ltd

Company Details